As of May 22
| +0.05 / +0.97%|
The 4 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +33.84% increase from the last price of 5.23.
The current consensus among 5 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.